30131.t000262
|
(1 of 3) PTHR11206//PTHR11206:SF116 - MULTIDRUG RESISTANCE PROTEIN // ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
R. communis v0.1
|
|
4796
|
30131: 1607052-1611847 |
30131.t000263
|
(1 of 3) PTHR11206//PTHR11206:SF116 - MULTIDRUG RESISTANCE PROTEIN // ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
R. communis v0.1
|
|
5192
|
30131: 1613098-1618289 |
30131.t000264
|
(1 of 3) PTHR11206//PTHR11206:SF116 - MULTIDRUG RESISTANCE PROTEIN // ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
R. communis v0.1
|
|
4902
|
30131: 1619748-1624649 |
Cucsa.109220
|
(1 of 1) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
C. sativus v1.0
|
|
14477
|
scaffold00934: 137687-152163 |
orange1.1g008932m.g
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
C. sinensis v1.1
|
|
5946
|
scaffold00474: 30977-36922 |
orange1.1g008695m.g
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
C. sinensis v1.1
|
|
4665
|
scaffold00474: 38261-42925 |
AT4G39030
|
(1 of 2) PTHR11206//PTHR11206:SF116 - MULTIDRUG RESISTANCE PROTEIN // ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
A. thaliana TAIR10
|
EDS5
|
3558
|
Chr4: 18185667-18189224 |
AT2G21340
|
(1 of 2) PTHR11206//PTHR11206:SF116 - MULTIDRUG RESISTANCE PROTEIN // ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
A. thaliana TAIR10
|
|
3905
|
Chr2: 9132555-9136459 |
Thhalv10024859m.g
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
E. salsugineum v1.0
|
|
3440
|
scaffold_1: 318811-322250 |
Thhalv10000106m.g
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
E. salsugineum v1.0
|
|
4091
|
scaffold_15: 148317-152407 |
Ciclev10028123m.g
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
C. clementina v1.0
|
|
4868
|
scaffold_8: 6293020-6297887 |
Ciclev10028133m.g
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
C. clementina v1.0
|
|
6029
|
scaffold_8: 6298166-6304194 |
Lus10041955.g
|
(1 of 5) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
L. usitatissimum v1.0
|
|
3769
|
scaffold123: 106714-110482 |
Lus10042074.g
|
(1 of 5) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
L. usitatissimum v1.0
|
|
3602
|
scaffold123: 580895-584496 |
Lus10017964.g
|
(1 of 5) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
L. usitatissimum v1.0
|
|
3557
|
scaffold687: 114007-117563 |
Lus10018080.g
|
(1 of 2) PF14667 - Polysaccharide biosynthesis C-terminal domain (Polysacc_synt_C) |
L. usitatissimum v1.0
|
|
3655
|
scaffold687: 611875-615529 |
Gorai.005G247600
|
(1 of 3) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
G. raimondii v2.1
|
|
6562
|
Chr05: 62743005-62749566 |
Gorai.005G247500
|
(1 of 3) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
G. raimondii v2.1
|
|
4014
|
Chr05: 62738552-62742565 |
Thecc1EG006799
|
(1 of 2) PTHR11206//PTHR11206:SF116 - MULTIDRUG RESISTANCE PROTEIN // ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
T. cacao v1.1
|
|
15377
|
scaffold_2: 3803760-3819136 |
Thecc1EG006803
|
(1 of 2) PTHR11206//PTHR11206:SF116 - MULTIDRUG RESISTANCE PROTEIN // ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
T. cacao v1.1
|
|
10465
|
scaffold_2: 3820110-3830574 |
Migut.B00187
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
M. guttatus v2.0
|
|
4775
|
scaffold_2: 778126-782900 |
Araha.2687s0007
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
A. halleri v1.1
|
|
3451
|
Scaffold2687: 41933-45383 |
Araha.68196s0003
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
A. halleri v1.1
|
|
4237
|
Scaffold68196: 3441-7677 |
Cagra.1383s0081
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
C. grandiflora v1.1
|
|
3408
|
Scaffold1383: 290346-293753 |
Cagra.2961s0035
|
(1 of 2) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
C. grandiflora v1.1
|
|
4061
|
Scaffold2961: 103656-107716 |
Glyma.11G112100
|
(1 of 3) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
G. max Wm82.a2.v1
|
|
5777
|
Chr11: 8549493-8555269 |
Glyma.11G112200
|
(1 of 3) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
G. max Wm82.a2.v1
|
|
6395
|
Chr11: 8558789-8565183 |
Brara.I04649
|
(1 of 3) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
B. rapa FPsc v1.3
|
|
3226
|
A09: 39944963-39948188 |
Brara.A00024
|
(1 of 3) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
B. rapa FPsc v1.3
|
|
3546
|
A01: 128461-132006 |
Bostr.5022s0102
|
(1 of 3) PTHR11206:SF116 - ENHANCED DISEASE SUSCEPTIBILITY 5-RELATED |
B. stricta v1.2
|
|
4104
|
Scaffold5022: 754902-759005 |